ARCHIVES

Isis 3521 Gets Fast-track Status For FDA Review.

This article is from The Cancer Letter archive.

Vol. 26 No. 44 | December 1, 2000

Download PDF Visit The Full Archive

Related Articles

Panel Says NIH Must Devise Means For Early Release Of Trials Data

January 25, 1991

ImClone Protocol Generates More Questions Than Answers.

February 15, 2002

NCI Director Halts STELLAR Trial, Seeks “Brilliant Ideas” For Breast Cancer Prevention.

March 2, 2007

New research Suggested For Immunobiology

November 18, 1977

Flood Says Congress Will Renew Cancer Act, But Only After “All Out” Review of Research Policy

December 3, 1976

House Committee Approves $1.9 Bil. NCI Budget

July 31, 1992